C-82 Topical Gel, 1%

DRUG2 trials

Sponsors

Prism Pharma Co., Ltd.

Conditions

PsoriasisSystemic Scleroderma

Phase 1

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

CompletedNCT02349009

Prism Pharma Co., Ltd.Systemic Scleroderma

Start: 2015-06-30End: 2016-09-30Updated: 2017-08-17

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

CompletedNCT02432027

Prism Pharma Co., Ltd.Psoriasis

Start: 2015-06-30End: 2015-09-30Updated: 2017-08-17